Back to Search
RANGA SANTOSH NARLA, PHARMD
PHARMD
Pharmacist
NPI: 1588144349Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
064423(NY)
Research & Publications (20)
Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation.
PMID 16927309·J Cell Biochem·2007
7-preclinical
The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.
PMID 16424030·Cancer Res·2006
7-preclinical
Phenylarsonic acid compounds with broad-spectrum and potent cytotoxic activity against human cancer cells.
PMID 12872614·Arzneimittelforschung·2003
8-other
Organic phenyl arsonic acid compounds with potent antileukemic activity.
PMID 12565976·Bioorg Med Chem Lett·2003
8-other
Structure-based design of novel anticancer agents.
PMID 12188892·Curr Cancer Drug Targets·2001
6-review
Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia.
PMID 11699220·Leuk Lymphoma·2001
8-other
In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
PMID 11448932·Clin Cancer Res·2001
7-preclinical
Apoptosis inducing novel anti-leukemic agent, bis(4,7-dimethyl-1,10 phenanthroline) sulfatooxovanadium(IV) [VO(SO4)(Me2-Phen)2] depolarizes mitochondrial membranes.
PMID 11378580·Leuk Lymphoma·2001
8-other
X-ray structure, solution properties, and biological activity profile of vanadocene(IV) acetylacetonate complex,.
PMID 11374587·J Inorg Biochem·2001
7-preclinical
Vanadocenes as potent anti-proliferative agents disrupting mitotic spindle formation in cancer cells.
PMID 11335794·Anticancer Drugs·2001
7-preclinical
Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(I.V.) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity.
PMID 11309362·Clin Cancer Res·2001
8-other
SPIKET and COBRA compounds as novel tubulin modulators with potent anticancer activity.
PMID 11249582·Curr Opin Investig Drugs·2000
6-review
Synthesis, X-ray structure, and anti-leukemic activity of oxovanadium(IV) complexes.
PMID 10857913·J Inorg Biochem·2000
8-other
A rationally designed anticancer drug targeting a unique binding cavity of tubulin.
PMID 10843205·Bioorg Med Chem Lett·2000
8-other
Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
PMID 10778988·Clin Cancer Res·2000
8-other
Apoptosis-inducing vanadocene compounds against human testicular cancer.
PMID 10778987·Clin Cancer Res·2000
8-other
EGF-genistein inhibits neointimal hyperplasia after vascular injury in an experimental restenosis model.
PMID 10774791·J Cardiovasc Pharmacol·2000
7-preclinical
The S-alkyl chain length as a determinant of the anti-leukemic activity of cysteine chloromethyl ketone compounds.
PMID 10741551·Bioorg Med Chem Lett·2000
8-other
Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity.
PMID 10741550·Bioorg Med Chem Lett·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 2ND AVE FRNT D
NEW YORK, NY 10017 - Phone
- (828) 384-2332
Quick Facts
- NPI
- 1588144349
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile